Latest Cancer: Bladder news
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
posted October 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASTRO Issues Guidance for Use of Radiation Therapy in Bladder Cancer
posted September 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer
posted August 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine
posted July 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment
Early Survivorship Care Linked to Improved Outcomes in Head, Neck Cancer
Response to Autologous HSCT Durable for Patients With Systemic Sclerosis
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer
Color Vision Deficiency Associated With Shorter Survival for Patients With Bladder Cancer
Meta-Analysis IDs Link Between Type 1 Diabetes and Bladder Cancer
Acute Cystitis Tied to Higher Risk for Urogenital Cancers